Abstract:Ademetionine 1,4-Butanedisulfonate (SAMe) is widely used as a prescription drug to treat cholestasis associated with liver disease, and is also used to treat depression, Alzheimer's disease and other diseases. Currently, the main way to produce SAMe is by fermentation of S-adenosylmethionine synthetase（SAMS）. However, during the fermentation process, host cells produce contaminants unrelated to the treatment. Among them, host cell protein (HCP), which is co-purified with the drug, is the main impurity in the production process. HCP-induced antigenic reactions can lead to allergies or other adverse reactions and affect drug quality, efficacy, and safety. Enzyme-linked immunosorbent assay (ELISA) and mass spectrometry (MS) are currently used as the main analytical methods for measuring HCP. The ELISA method may ignore some HCPs with low immunogenicity, while mass spectrometry is primarily employed for the characterization of proteomes. Orthogonal methods can more effectively evaluate impurities in drugs. In this study, ELISA was initially utilized to quantify the content of Saccharomyces cerevisiae host protein in 11 batches of SAMe active pharmaceutical ingredient (API) from two suppliers, then the above APIs were qualitatively analyzed by MS method. Following the identification of surrogate peptide of SAMS, an Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry（UPLC-MS/MS）method was established and validated, the SAMS protein residues in 11 batches of samples were subsequently determined. The results demonstrated that the levels of Saccharomyces cerevisiae host protein and SAMS in the samples were both low, with values below 20 ppm and 1.19 ppm, respectively. The qualitative results also indicate that the types of peptide residues in the samples are more diverse than those of protein residues. Furthermore, residues of proteins and peptides can be detected in all samples, which underscores the importance of evaluating the HCP in API. This study employs a range of complementary detection methods to conduct a comprehensive and sensitive evaluation of total HCP and specific proteins in drugs, thereby guiding more informed assessments of the risks posed by HCP impurities in raw materials during pharmaceutical processes.

Secreted Expression of S-adenosy-L-methionine Synthetase in Pichia Pastoris

Engineered Pichia pastoris for enhanced production of S-adenosylmethionine

[Enhancement of the Production of SAM by Overexpression of SAM Synthetase in Pichia Pastoris].

High Expression of Thermostable Xylanase XYNB from Aspergillus Niger in Pichia Pastoris

A synergistic effect on the production of S-adenosyl-l-methionine in Pichia pastoris by knocking in of S-adenosyl-l-methionine synthase and knocking out of cystathionine-β synthase

Efficient Production of S-adenosyl-l-methionine from Dl-Methionine in Metabolic Engineered Saccharomyces Cerevisiae.

Expression of Ascaris suum cecropin P1 gene in Pichia pastoris and its antimicrobial activity

Semi-rationally Engineered Variants of S-adenosylmethionine Synthetase from Escherichia Coli with Reduced Product Inhibition and Improved Catalytic Activity.

The Improvement of SAM Accumulation by Integrating the Endogenous Methionine Adenosyltransferase Gene SAM2 in Genome of the Industrial Saccharomyces cerevisiae Strain

Metabolic engineering of Bacillus amyloliquefaciens for enhanced production of S-adenosylmethionine by coupling of an engineered S-adenosylmethionine pathway and the tricarboxylic acid cycle

Engineering of a Pichia pastoris Expression System for High-Level Secretion of HSA/GH Fusion Protein

Improving the Productivity of S-adenosyl-l-methionine by Metabolic Engineering in an Industrial Saccharomyces Cerevisiae Strain.

Overexpression of Yeast S -Adenosylmethionine Synthetase Metk in Streptomyces Actuosus Leads to Increased Production of Nosiheptide

Enhanced synthesis of S‐adenosyl‐L‐methionine through combinatorial metabolic engineering and Bayesian optimization in Saccharomyces cerevisiae

Untargeted Metabolomics Combined with Metabolic Flux Analysis Reveals the Mechanism of Sodium Citrate for High S-Adenosyl-Methionine Production by Pichia pastoris

Expression and Characterization of Recombinant Porcine Β-Defensin-2 Gene in Pichia Pastoris

Multilevel metabolic engineering for enhanced synthesis of S-adenosylmethionine by Bacillus amyloliquefaciens

Expression of recombinant proteins in the methylotrophic yeast Pichia pastoris

SAMY, a novel mammalian reporter gene derived from Bacillus stearothermophilus alpha-amylase

Identification of novel metabolic engineering targets for S-adenosyl-L-methionine production in Saccharomyces cerevisiae via genome-scale engineering.

Evaluation of Protein Impurities in Ademetionine 1,4-Butanedisulfonate